Evaluation of anti-vascular therapy with texture analysis

被引:0
|
作者
Chen, G [1 ]
Jespersen, S
Pedersen, M
Pang, Q
Horsman, MR
Jorgensen, HS
机构
[1] Aarhus Univ Hosp, MR Res Ctr, DK-8200 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Expt Oncol, DK-8000 Aarhus, Denmark
[3] Shandong Univ, Shandong Prov Hosp, Dept Neurosurg, Jinan 250021, Peoples R China
关键词
magnetic resonance imaging; texture analysis; carcinoma; boot strap statistics;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Texture analysis can be used to identify and discriminate between objects in an image and has already been used for the characterization of diseases. The present study evaluated the potential of texture analysis for monitoring tumor cell viability during treatment with an anti-vascular drug. Materials and Methods: Texture analysis of T-2-weighted magnetic resonance images of C3H mammary carcinomas in mice was used to study tumor cell viability during treatment with the anti-vascular drug combretastatin A-4 disodium phosphate (CA4DP). Texture analysis was done by MaZda((R)), and boot strap statistics were used to analyze the results. Results: The results revealed significant differences in the textures of T-2-weighted images when non-tumor tissue and tumor tissue were compared. Furthermore, selected texture parameters were significantly different when image data from before and after CA4DP administration were analyzed. Conclusion: Texture analysis is helpful in the diagnosis of different types of tissues, especially when these tissues can not be recognized by human observers. Some functional changes, such as perfusion changes in the tumor, can also be detected by texture analysis.
引用
收藏
页码:3399 / 3405
页数:7
相关论文
共 50 条
  • [41] Photodynamic therapy, anti-vascular endothelial growth factor therapy, and combination therapy for polypoidal choroidal vasculopathy
    Kang, Hae Min
    Lee, Naeun
    Koh, Hyoung Jun
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [42] Beyond Intravitreal Injection of Anti-Vascular Endothelial Growth Factor (VEGF) Therapy
    d'Amico, G.
    Caporossi, T.
    Pagliara, M. M.
    Molle, F.
    Lepore, D.
    Focosi, F.
    Balestrazzi, E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [43] ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NAIVE IDIOPATHIC CHOROIDAL NEOVASCULARIZATION
    Sudhalkar, Aditya
    Yogi, Rohit
    Chhablani, Jay
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (07): : 1368 - 1374
  • [44] ANTI-VASCULAR AND ANTI-ANGIOGENIC EFFECTS OF HYPERTHERMIA
    Hager, E. Dieter
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3690 - 3691
  • [45] Light-Activated Anti-Vascular Combination Therapy against Choroidal Neovascularization
    Xu, Shuting
    Li, Jia
    Long, Kaiqi
    Liang, Xiaoling
    Wang, Weiping
    ADVANCED SCIENCE, 2024,
  • [46] Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer: Game Over?
    Sledge, George W.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (02) : 133 - 135
  • [47] Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy
    Gee, MS
    Procopio, WN
    Makonnen, S
    Feldman, MD
    Yeilding, NM
    Lee, WMF
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01): : 183 - 193
  • [48] Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?
    Nitkin, Christopher R.
    Richardson, Troy
    Lewis, Tamorah
    JAMA OPHTHALMOLOGY, 2023, 141 (04) : 407 - 408
  • [49] Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy
    Yang, AD
    Bauer, TW
    Camp, ER
    Somcio, R
    Liu, WB
    Fan, F
    Ellis, LM
    CANCER, 2005, 103 (08) : 1561 - 1570
  • [50] The direct effects of anti-vascular endothelial growth factor therapy on tumor cells
    Moser, Christian
    Lang, Sven A.
    Stoeltzing, Oliver
    CLINICAL COLORECTAL CANCER, 2007, 6 (08) : 564 - 571